We are pleased to announce that Glycoscience has been selected among more than 700 applications to be part of the 25 finalist startups participating in the 11th edition of B-Venture, one of the leading entrepreneurship and investment forums in northern Spain.
On April 21–22, at the Euskalduna Conference Centre in Bilbao, we will have the opportunity to present and defend our project before investors and business angels, showcasing our biotechnology-based solutions for the development of high-efficacy natural insect repellents and agrochemicals.
Being part of this event is an important recognition of the work of our team and the potential of our technologies to deliver innovative and sustainable solutions to current challenges in public health and agriculture.
We thank the B-Venture organization for this opportunity and look forward to sharing our vision with the entrepreneurial and investment ecosystem.
